What will Amgen’s new chief do with $20B cache?

Some analysts say that the new CEO at Amgen ($AMGN)--Bob Bradway (photo)--will need to pull off more licensing and buyout deals if he wants to earn a good reputation for an up-an-coming pipeline effor…
Read the full story: News